88/100B443.58
USD
3.63
(0.82%)
Post Trading·442.99USD-0.59(-0.13%)
Last updated: · Delayed 15 min
Fair value591.36Plus-25%314Price 443.58807
Q4 FY2026 · Earnings report
EPS estimate 2.96Revenue estimate 3.24B
Q4 FY2026 · Earnings report
EPS estimate 2.96Revenue estimate 3.24B
Intuitive Surgical price to sales (P/S) ratioWhat is the P/S ratio? The price-to-sales ratio compares a company's market value with its revenue over the last year: what you pay for each dollar of sales.
Intuitive Surgical's P/S ratio is 13.28: its market cap of 153.76B USD over revenue of 11.58B USD in the last twelve months.
- Today
- 13.28
- Average, 5 years
- 17.73
- Low, 5 years
- 10.67
- High, 5 years
- 27.61
P/S ratio = market cap ÷ revenue (last 12 months) = 153.76B ÷ 11.58B = 13.28
Each day's market cap over the revenue of the last four quarters reported by that day.
P/S ratio by year and by quarter
| Fiscal year | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Today | 13.28 | 153.76B | 11.58B | |
| FY2025 | 31 Dec 2025 | 20.08 | 202.13B | 10.06B |
| FY2024 | 31 Dec 2024 | 22.20 | 185.40B | 8.35B |
| FY2023 | 31 Dec 2023 | 16.63 | 118.48B | 7.12B |
| FY2022 | 31 Dec 2022 | 15.17 | 94.38B | 6.22B |
| FY2021 | 31 Dec 2021 | 22.41 | 127.95B | 5.71B |
| FY2020 | 31 Dec 2020 | 21.96 | 95.72B | 4.36B |
| FY2019 | 31 Dec 2019 | 15.23 | 68.22B | 4.48B |
| FY2018 | 31 Dec 2018 | 14.62 | 54.45B | 3.72B |
| FY2017 | 31 Dec 2017 | 13.03 | 40.76B | 3.13B |
| FY2016 | 31 Dec 2016 | 8.98 | 24.29B | 2.70B |
| FY2015 | 31 Dec 2015 | 8.50 | 20.26B | 2.38B |
| FY2014 | 31 Dec 2014 | 9.16 | 19.52B | 2.13B |
| FY2013 | 31 Dec 2013 | 6.80 | 15.41B | 2.27B |
| FY2012 | 31 Dec 2012 | 8.96 | 19.52B | 2.18B |
| FY2011 | 31 Dec 2011 | 10.33 | 18.15B | 1.76B |
| FY2010 | 31 Dec 2010 | 7.15 | 10.10B | 1.41B |
| FY2009 | 31 Dec 2009 | 11.04 | 11.62B | 1.05B |
| FY2008 | 31 Dec 2008 | 5.64 | 4.94B | 874.92M |
| FY2007 | 31 Dec 2007 | 20.34 | 12.22B | 600.83M |
| FY2006 | 31 Dec 2006 | 9.46 | 3.52B | 372.68M |
| FY2005 | 31 Dec 2005 | 18.09 | 4.11B | 227.34M |
| FY2004 | 31 Dec 2004 | 9.72 | 1.35B | 138.80M |
| FY2003 | 31 Dec 2003 | 4.41 | 404.00M | 91.68M |
| FY2002 | 31 Dec 2002 | 3.12 | 224.76M | 72.02M |
| FY2001 | 31 Dec 2001 | 6.96 | 359.41M | 51.67M |
| FY2000 | 31 Dec 2000 | 7.60 | 202.38M | 26.62M |
| FY1999 | 31 Dec 1999 | 4.34 | 44.19M | 10.19M |
| FY1998 | 31 Dec 1998 | — | 33.06M | 0.00 |
| Quarter | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 12.26 | 141.91B | 11.58B |
| Q2 FY2026 | 30 Jun 2026 | 12.78 | 140.98B | 11.03B |
| Q1 FY2026 | 31 Mar 2026 | 15.46 | 163.61B | 10.58B |
| Q4 FY2025 | 31 Dec 2025 | 19.97 | 201.00B | 10.06B |
| Q3 FY2025 | 30 Sept 2025 | 16.59 | 159.48B | 9.61B |
| Q2 FY2025 | 30 Jun 2025 | 21.30 | 194.81B | 9.15B |
| Q1 FY2025 | 31 Mar 2025 | 20.32 | 177.06B | 8.71B |
| Q4 FY2024 | 31 Dec 2024 | 22.27 | 186.03B | 8.35B |
| Q3 FY2024 | 30 Sept 2024 | 22.22 | 174.79B | 7.87B |
| Q2 FY2024 | 30 Jun 2024 | 20.45 | 154.87B | 7.57B |
| Q1 FY2024 | 31 Mar 2024 | 19.07 | 139.59B | 7.32B |
| Q4 FY2023 | 31 Dec 2023 | 16.67 | 118.78B | 7.12B |
| Q3 FY2023 | 30 Sept 2023 | 15.01 | 102.80B | 6.85B |
| Q2 FY2023 | 30 Jun 2023 | 18.00 | 119.99B | 6.66B |
| Q1 FY2023 | 31 Mar 2023 | 13.91 | 89.47B | 6.43B |
| Q4 FY2022 | 31 Dec 2022 | 14.97 | 93.16B | 6.22B |
| Q3 FY2022 | 30 Sept 2022 | 10.89 | 66.60B | 6.12B |
| Q2 FY2022 | 30 Jun 2022 | 12.05 | 71.87B | 5.96B |
| Q1 FY2022 | 31 Mar 2022 | 18.31 | 108.12B | 5.91B |
| Q4 FY2021 | 31 Dec 2021 | 22.50 | 128.45B | 5.71B |
| Q3 FY2021 | 30 Sept 2021 | 21.54 | 118.24B | 5.49B |
| Q2 FY2021 | 30 Jun 2021 | 21.13 | 109.07B | 5.16B |
| Q1 FY2021 | 31 Mar 2021 | 19.13 | 87.05B | 4.55B |
| Q4 FY2020 | 31 Dec 2020 | 22.07 | 96.21B | 4.36B |
| Q3 FY2020 | 30 Sept 2020 | 19.32 | 83.23B | 4.31B |
| Q2 FY2020 | 30 Jun 2020 | 15.27 | 66.55B | 4.36B |
| Q1 FY2020 | 31 Mar 2020 | 12.52 | 57.64B | 4.60B |
| Q4 FY2019 | 31 Dec 2019 | 15.29 | 68.46B | 4.48B |
| Q3 FY2019 | 30 Sept 2019 | 14.67 | 62.31B | 4.25B |
| Q2 FY2019 | 30 Jun 2019 | 15.12 | 61.08B | 4.04B |
| Q1 FY2019 | 31 Mar 2019 | 17.19 | 66.19B | 3.85B |
| Q4 FY2018 | 31 Dec 2018 | 14.74 | 54.88B | 3.72B |
| Q3 FY2018 | 30 Sept 2018 | 18.35 | 65.52B | 3.57B |
| Q2 FY2018 | 30 Jun 2018 | 15.74 | 54.40B | 3.46B |
| Q1 FY2018 | 31 Mar 2018 | 14.10 | 46.57B | 3.30B |
| Q4 FY2017 | 31 Dec 2017 | 13.09 | 40.95B | 3.13B |
| Q3 FY2017 | 30 Sept 2017 | 13.02 | 38.98B | 2.99B |
| Q2 FY2017 | 30 Jun 2017 | 12.06 | 34.61B | 2.87B |
| Q1 FY2017 | 31 Mar 2017 | 10.27 | 28.59B | 2.78B |
| Q4 FY2016 | 31 Dec 2016 | 9.10 | 24.60B | 2.70B |
| Q3 FY2016 | 30 Sept 2016 | 10.69 | 28.05B | 2.62B |
| Q2 FY2016 | 30 Jun 2016 | 10.01 | 25.33B | 2.53B |
| Q1 FY2016 | 31 Mar 2016 | 9.26 | 22.66B | 2.45B |
| Q4 FY2015 | 31 Dec 2015 | 8.54 | 20.37B | 2.38B |
| Q3 FY2015 | 30 Sept 2015 | 7.41 | 17.14B | 2.31B |
| Q2 FY2015 | 30 Jun 2015 | 7.86 | 17.88B | 2.27B |
| Q1 FY2015 | 31 Mar 2015 | 8.43 | 18.53B | 2.20B |
| Q4 FY2014 | 31 Dec 2014 | 9.01 | 19.20B | 2.13B |
| Q3 FY2014 | 30 Sept 2014 | 7.93 | 16.67B | 2.10B |
| Q2 FY2014 | 30 Jun 2014 | 7.41 | 15.20B | 2.05B |
| Q1 FY2014 | 31 Mar 2014 | 8.10 | 17.17B | 2.12B |
| Q4 FY2013 | 31 Dec 2013 | 6.58 | 14.90B | 2.27B |
| Q3 FY2013 | 30 Sept 2013 | 6.32 | 14.52B | 2.30B |
| Q2 FY2013 | 30 Jun 2013 | 8.56 | 20.01B | 2.34B |
| Q1 FY2013 | 31 Mar 2013 | 8.51 | 19.53B | 2.30B |
| Q4 FY2012 | 31 Dec 2012 | 9.00 | 19.62B | 2.18B |
| Q3 FY2012 | 30 Sept 2012 | 9.65 | 19.94B | 2.07B |
| Q2 FY2012 | 30 Jun 2012 | 11.19 | 22.10B | 1.98B |
| Q1 FY2012 | 31 Mar 2012 | 11.48 | 21.40B | 1.86B |
| Q4 FY2011 | 31 Dec 2011 | 10.33 | 18.15B | 1.76B |
| Q3 FY2011 | 30 Sept 2011 | 8.63 | 14.24B | 1.65B |
| Q2 FY2011 | 30 Jun 2011 | 9.43 | 14.59B | 1.55B |
| Q1 FY2011 | 31 Mar 2011 | 8.85 | 13.04B | 1.47B |
| Q4 FY2010 | 31 Dec 2010 | 7.13 | 10.08B | 1.41B |
| Q3 FY2010 | 30 Sept 2010 | 8.30 | 11.18B | 1.35B |
| Q2 FY2010 | 30 Jun 2010 | 9.67 | 12.40B | 1.28B |
| Q1 FY2010 | 31 Mar 2010 | 11.33 | 13.51B | 1.19B |
| Q4 FY2009 | 31 Dec 2009 | 11.04 | 11.62B | 1.05B |
| Q3 FY2009 | 30 Sept 2009 | 10.40 | 9.99B | 960.68M |
| Q2 FY2009 | 30 Jun 2009 | 6.77 | 6.20B | 916.53M |
| Q1 FY2009 | 31 Mar 2009 | 4.24 | 3.71B | 875.10M |
| Q4 FY2008 | 31 Dec 2008 | 5.64 | 4.94B | 874.92M |
| Q3 FY2008 | 30 Sept 2008 | 11.29 | 9.40B | 832.82M |
| Q2 FY2008 | 30 Jun 2008 | 13.86 | 10.44B | 753.73M |
| Q1 FY2008 | 31 Mar 2008 | 18.55 | 12.51B | 674.79M |
| Q4 FY2007 | 31 Dec 2007 | 20.63 | 12.39B | 600.83M |
| Q3 FY2007 | 30 Sept 2007 | 16.80 | 8.80B | 523.95M |
| Q2 FY2007 | 30 Jun 2007 | 11.28 | 5.22B | 462.88M |
| Q1 FY2007 | 31 Mar 2007 | 11.07 | 4.53B | 409.65M |
| Q4 FY2006 | 31 Dec 2006 | 9.53 | 3.55B | 372.68M |
| Q3 FY2006 | 30 Sept 2006 | 11.71 | 3.89B | 332.21M |
| Q2 FY2006 | 30 Jun 2006 | 14.19 | 4.22B | 297.25M |
| Q1 FY2006 | 31 Mar 2006 | 16.32 | 4.29B | 262.98M |
| Q4 FY2005 | 31 Dec 2005 | 18.48 | 4.20B | 227.34M |
| Q3 FY2005 | 30 Sept 2005 | 12.85 | 2.58B | 200.44M |
| Q2 FY2005 | 30 Jun 2005 | 9.27 | 1.62B | 175.06M |
| Q1 FY2005 | 31 Mar 2005 | 10.23 | 1.57B | 153.36M |
| Q4 FY2004 | 31 Dec 2004 | 9.84 | 1.37B | 138.80M |
| Q3 FY2004 | 30 Sept 2004 | 6.91 | 837.12M | 121.20M |
| Q2 FY2004 | 30 Jun 2004 | 5.84 | 637.29M | 109.10M |
| Q1 FY2004 | 31 Mar 2004 | 5.69 | 566.13M | 99.50M |
| Q4 FY2003 | 31 Dec 2003 | 6.21 | 569.12M | 91.68M |
| Q3 FY2003 | 30 Sept 2003 | 5.25 | 447.52M | 85.23M |
| Q2 FY2003 | 30 Jun 2003 | 3.52 | 277.59M | 78.91M |
| Q1 FY2003 | 31 Mar 2003 | 3.11 | 238.87M | 76.85M |
| Q4 FY2002 | 31 Dec 2002 | 3.14 | 225.89M | 72.02M |
| Q3 FY2002 | 30 Sept 2002 | 4.37 | 292.36M | 66.89M |
| Q2 FY2002 | 30 Jun 2002 | 4.91 | 297.98M | 60.67M |
| Q1 FY2002 | 31 Mar 2002 | 6.29 | 339.84M | 54.00M |
| Q4 FY2001 | 31 Dec 2001 | 7.02 | 362.79M | 51.67M |
| Q3 FY2001 | 30 Sept 2001 | 5.04 | 233.64M | 46.37M |
| Q2 FY2001 | 30 Jun 2001 | 11.10 | 481.34M | 43.36M |
| Q1 FY2001 | 31 Mar 2001 | 4.81 | 172.05M | 35.77M |
| Q4 FY2000 | 31 Dec 2000 | 11.22 | 298.83M | 26.63M |
| Q3 FY2000 | 30 Sept 2000 | — | 407.14M | — |
| Q2 FY2000 | 30 Jun 2000 | — | 187.19M | — |
| Q1 FY2000 | 31 Mar 2000 | — | 50.92M | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,ROE (return on equity),Debt to equity,Current ratio,All ratios
Common questions about Intuitive Surgical's P/S ratio
Source: Financial Modeling PrepVerified against SEC filings